(-)-demecolcine increases expression ISO RGD:1348952 6480464 Demecolcine results in increased expression of ATP2B4 mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate increases expression ISO RGD:1348952 6480464 epigallocatechin gallate results in increased expression of ATP2B4 mRNA CTD PMID:22079256 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1348952 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ATP2B4 mRNA CTD PMID:22079256 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of ATP2B4 mRNA CTD PMID:29097150 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of ATP2B4 mRNA CTD PMID:26496021 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1550638 6480464 [2 more ... CTD PMID:25510870 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1348952 6480464 2 more ... CTD PMID:31675489 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1550638 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1550638 6480464 Tetrachlorodibenzodioxin affects the expression of ATP2B4 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ATP2B4 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of ATP2B4 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1550638 6480464 Tetrachlorodibenzodioxin results in decreased expression of ATP2B4 mRNA CTD PMID:29673856 2,4,6-tribromophenol increases expression ISO RGD:1348952 6480464 2 more ... CTD PMID:31675489 2-hydroxypropanoic acid increases expression ISO RGD:1348952 6480464 Lactic Acid results in increased expression of ATP2B4 mRNA CTD PMID:30851411 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:1550638 6480464 tetrabromobisphenol A results in decreased expression of ATP2B4 mRNA CTD PMID:25172293 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:1348952 6480464 tetrabromobisphenol A results in increased expression of ATP2B4 protein CTD PMID:31675489 4,4'-sulfonyldiphenol increases expression ISO RGD:1550638 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of ATP2B4 mRNA CTD PMID:30951980 5-aza-2'-deoxycytidine affects expression ISO RGD:1348952 6480464 Decitabine affects the expression of ATP2B4 mRNA CTD PMID:23300844 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of ATP2B4 mRNA CTD PMID:24780913 acrolein multiple interactions ISO RGD:1348952 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ATP2B4 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ATP2B4 mRNA CTD PMID:32699268 acrylamide decreases expression ISO RGD:1348952 6480464 Acrylamide results in decreased expression of ATP2B4 mRNA CTD PMID:32763439 aflatoxin B1 increases methylation ISO RGD:1348952 6480464 Aflatoxin B1 results in increased methylation of ATP2B4 gene, Aflatoxin B1 results in increased methylation of ATP2B4 intron CTD PMID:27153756 , PMID:30157460 aflatoxin B1 increases expression ISO RGD:1348952 6480464 Aflatoxin B1 results in increased expression of ATP2B4 mRNA CTD PMID:32234424 alpha-pinene multiple interactions ISO RGD:1348952 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ATP2B4 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ATP2B4 mRNA CTD PMID:32699268 ammonium acetate decreases expression EXP 6480464 ammonium acetate results in decreased expression of ATP2B4 protein CTD PMID:33404927 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ATP2B4 mRNA CTD PMID:16483693 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of ATP2B4 mRNA CTD PMID:30779732 arsane affects expression ISO RGD:1348952 6480464 Arsenic affects the expression of ATP2B4 mRNA CTD PMID:18414638 arsenic atom affects expression ISO RGD:1348952 6480464 Arsenic affects the expression of ATP2B4 mRNA CTD PMID:18414638 arsenite(3-) multiple interactions ISO RGD:1348952 6480464 arsenite inhibits the reaction [G3BP1 protein binds to ATP2B4 mRNA] CTD PMID:32406909 atrazine increases expression ISO RGD:1348952 6480464 Atrazine results in increased expression of ATP2B4 mRNA CTD PMID:22378314 atrazine affects expression ISO RGD:1550638 6480464 Atrazine affects the expression of ATP2B4 mRNA CTD PMID:26476475 , PMID:27112537 atrazine multiple interactions ISO RGD:1550638 6480464 Lycopene inhibits the reaction [Atrazine affects the expression of ATP2B4 mRNA] CTD PMID:26476475 , PMID:27112537 Benoxacor increases expression ISO RGD:1550638 6480464 benoxacor results in increased expression of ATP2B4 mRNA CTD PMID:34850242 benzo[a]pyrene decreases expression ISO RGD:1348952 6480464 Benzo(a)pyrene results in decreased expression of ATP2B4 mRNA CTD PMID:20064835 benzo[a]pyrene increases expression ISO RGD:1348952 6480464 Benzo(a)pyrene results in increased expression of ATP2B4 mRNA CTD PMID:32234424 benzo[a]pyrene affects methylation ISO RGD:1348952 6480464 Benzo(a)pyrene affects the methylation of ATP2B4 3' UTR more ... CTD PMID:27901495 , PMID:30157460 benzo[a]pyrene increases expression ISO RGD:1550638 6480464 Benzo(a)pyrene results in increased expression of ATP2B4 mRNA CTD PMID:32417428 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of ATP2B4 mRNA CTD PMID:26496021 bisphenol A decreases expression ISO RGD:1348952 6480464 bisphenol A results in decreased expression of ATP2B4 protein CTD PMID:31675489 , PMID:33376534 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ATP2B4 mRNA CTD PMID:25181051 more ... butan-1-ol multiple interactions ISO RGD:1348952 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ATP2B4 mRNA CTD PMID:29432896 calcium atom increases export ISO RGD:1348952 6480464 ATP2B4 protein results in increased export of Calcium CTD PMID:16452157 calcium atom multiple interactions ISO RGD:1348952 6480464 caloxin 1b1 inhibits the reaction [ATP2B4 protein results in increased export of Calcium] CTD PMID:16452157 calcium(0) increases export ISO RGD:1348952 6480464 ATP2B4 protein results in increased export of Calcium CTD PMID:16452157 calcium(0) multiple interactions ISO RGD:1348952 6480464 caloxin 1b1 inhibits the reaction [ATP2B4 protein results in increased export of Calcium] CTD PMID:16452157 CGP 52608 multiple interactions ISO RGD:1348952 6480464 CGP 52608 promotes the reaction [RORA protein binds to ATP2B4 gene] CTD PMID:28238834 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of ATP2B4 mRNA CTD PMID:18668222 chlorpyrifos increases expression ISO RGD:1550638 6480464 Chlorpyrifos results in increased expression of ATP2B4 mRNA CTD PMID:32715474 cisplatin affects expression ISO RGD:1348952 6480464 Cisplatin affects the expression of ATP2B4 mRNA CTD PMID:23300844 cobalt dichloride increases expression ISO RGD:1348952 6480464 cobaltous chloride results in increased expression of ATP2B4 mRNA CTD PMID:19376846 copper atom multiple interactions ISO RGD:1348952 6480464 [NSC 689534 binds to Copper] which results in increased expression of ATP2B4 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1348952 6480464 [NSC 689534 binds to Copper] which results in increased expression of ATP2B4 mRNA CTD PMID:20971185 cyclosporin A decreases expression ISO RGD:1348952 6480464 Cyclosporine results in decreased expression of ATP2B4 mRNA CTD PMID:25562108 decabromodiphenyl ether increases expression ISO RGD:1348952 6480464 decabromobiphenyl ether results in increased expression of ATP2B4 protein CTD PMID:31675489 dexamethasone increases expression ISO RGD:1348952 6480464 Dexamethasone results in increased expression of ATP2B4 mRNA CTD PMID:25047013 dicrotophos increases expression ISO RGD:1348952 6480464 dicrotophos results in increased expression of ATP2B4 mRNA CTD PMID:28302478 Didecyldimethylammonium decreases expression ISO RGD:1348952 6480464 didecyldimethylammonium results in decreased expression of ATP2B4 mRNA CTD PMID:32763356 dioxygen increases expression ISO RGD:1550638 6480464 Oxygen deficiency results in increased expression of ATP2B4 mRNA CTD PMID:24205000 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ATP2B4 mRNA CTD PMID:33729688 dorsomorphin multiple interactions ISO RGD:1348952 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1348952 6480464 Doxorubicin results in decreased expression of ATP2B4 mRNA CTD PMID:29803840 elemental selenium increases expression ISO RGD:1348952 6480464 Selenium results in increased expression of ATP2B4 mRNA CTD PMID:19244175 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of ATP2B4 mRNA CTD PMID:29391264 epoxiconazole increases expression ISO RGD:1550638 6480464 epoxiconazole results in increased expression of ATP2B4 mRNA CTD PMID:35436446 ethanol decreases expression ISO RGD:1550638 6480464 Ethanol results in decreased expression of ATP2B4 mRNA CTD PMID:29018328 ethanol increases expression ISO RGD:1550638 6480464 Ethanol results in increased expression of ATP2B4 mRNA CTD PMID:30319688 ethanol affects splicing ISO RGD:1550638 6480464 Ethanol affects the splicing of ATP2B4 mRNA CTD PMID:30319688 fenofibrate increases expression ISO RGD:1348952 6480464 Fenofibrate results in increased expression of ATP2B4 mRNA CTD PMID:25572481 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of ATP2B4 mRNA CTD PMID:30307764 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of ATP2B4 mRNA CTD PMID:18035473 formaldehyde increases expression ISO RGD:1348952 6480464 Formaldehyde results in increased expression of ATP2B4 mRNA CTD PMID:23649840 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of ATP2B4 mRNA CTD PMID:33387578 irinotecan decreases response to substance ISO RGD:1348952 6480464 ATP2B4 protein results in decreased susceptibility to Irinotecan CTD PMID:16734730 isotretinoin increases expression ISO RGD:1348952 6480464 Isotretinoin results in increased expression of ATP2B4 mRNA CTD PMID:20436886 lead(0) affects splicing ISO RGD:1348952 6480464 Lead affects the splicing of ATP2B4 mRNA CTD PMID:28903495 lead(2+) affects splicing ISO RGD:1348952 6480464 Lead affects the splicing of ATP2B4 mRNA CTD PMID:28903495 lipopolysaccharide multiple interactions ISO RGD:1348952 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ATP2B4 mRNA CTD PMID:35811015 lycopene multiple interactions ISO RGD:1550638 6480464 Lycopene inhibits the reaction [Atrazine affects the expression of ATP2B4 mRNA] CTD PMID:26476475 , PMID:27112537 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of ATP2B4 mRNA CTD PMID:28801915 medroxyprogesterone acetate decreases expression ISO RGD:1348952 6480464 Medroxyprogesterone Acetate results in decreased expression of ATP2B4 mRNA CTD PMID:20843944 methotrexate increases expression ISO RGD:1348952 6480464 Methotrexate results in increased expression of ATP2B4 mRNA CTD PMID:21678067 methylseleninic acid increases expression ISO RGD:1348952 6480464 methylselenic acid results in increased expression of ATP2B4 mRNA CTD PMID:18548127 nickel sulfate decreases expression ISO RGD:1348952 6480464 nickel sulfate results in decreased expression of ATP2B4 mRNA CTD PMID:22714537 ozone multiple interactions ISO RGD:1348952 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ATP2B4 mRNA more ... CTD PMID:32699268 paracetamol increases expression ISO RGD:1348952 6480464 Acetaminophen results in increased expression of ATP2B4 mRNA CTD PMID:29067470 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of ATP2B4 mRNA CTD PMID:33387578 PCB138 multiple interactions ISO RGD:1550638 6480464 [2 more ... CTD PMID:25510870 perfluorononanoic acid increases expression ISO RGD:1348952 6480464 perfluoro-n-nonanoic acid results in increased expression of ATP2B4 mRNA CTD PMID:32588087 phenylephrine increases response to substance ISO RGD:1348952 6480464 ATP2B4 protein results in increased susceptibility to Phenylephrine CTD PMID:12933703 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of ATP2B4 mRNA CTD PMID:12832660 potassium chromate decreases expression ISO RGD:1348952 6480464 potassium chromate(VI) results in decreased expression of ATP2B4 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:1348952 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ATP2B4 mRNA CTD PMID:22079256 progesterone decreases expression ISO RGD:1348952 6480464 Progesterone results in decreased expression of ATP2B4 mRNA CTD PMID:18070364 prostaglandin F2alpha increases response to substance ISO RGD:1348952 6480464 ATP2B4 protein results in increased susceptibility to Dinoprost CTD PMID:12933703 rac-lactic acid increases expression ISO RGD:1348952 6480464 Lactic Acid results in increased expression of ATP2B4 mRNA CTD PMID:30851411 S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO RGD:1348952 6480464 S-(1, 2-dichlorovinyl)cysteine results in decreased expression of ATP2B4 mRNA CTD PMID:33725128 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1348952 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ATP2B4 mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:1348952 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 selenium atom increases expression ISO RGD:1348952 6480464 Selenium results in increased expression of ATP2B4 mRNA CTD PMID:19244175 silicon dioxide decreases expression ISO RGD:1348952 6480464 Silicon Dioxide analog results in decreased expression of ATP2B4 mRNA CTD PMID:25895662 sodium arsenate increases expression ISO RGD:1550638 6480464 sodium arsenate results in increased expression of ATP2B4 mRNA CTD PMID:21795629 sulforaphane decreases expression ISO RGD:1348952 6480464 sulforaphane results in decreased expression of ATP2B4 mRNA CTD PMID:31838189 sunitinib decreases expression ISO RGD:1348952 6480464 Sunitinib results in decreased expression of ATP2B4 mRNA CTD PMID:31533062 temozolomide decreases expression ISO RGD:1348952 6480464 Temozolomide results in decreased expression of ATP2B4 mRNA CTD PMID:31758290 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ATP2B4 mRNA CTD PMID:34492290 trichostatin A increases expression ISO RGD:1348952 6480464 trichostatin A results in increased expression of ATP2B4 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1348952 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP2B4 mRNA CTD PMID:27188386 triptonide affects expression ISO RGD:1550638 6480464 triptonide affects the expression of ATP2B4 mRNA CTD PMID:33045310 valproic acid decreases methylation ISO RGD:1348952 6480464 Valproic Acid results in decreased methylation of ATP2B4 gene CTD PMID:29154799 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of ATP2B4 mRNA CTD PMID:29427782 valproic acid increases expression ISO RGD:1348952 6480464 Valproic Acid results in increased expression of ATP2B4 mRNA CTD PMID:19101580 more ... valproic acid multiple interactions ISO RGD:1348952 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP2B4 mRNA CTD PMID:27188386 valproic acid affects expression ISO RGD:1348952 6480464 Valproic Acid affects the expression of ATP2B4 mRNA CTD PMID:25979313 vincristine increases expression ISO RGD:1348952 6480464 Vincristine results in increased expression of ATP2B4 mRNA CTD PMID:23649840 zalcitabine multiple interactions EXP 6480464 [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in increased expression of ATP2B4 mRNA CTD PMID:18606552
